Should You Be Concerned About This CT Head Finding?
You should not be overly alarmed by this CT report, but you do need pituitary hormone testing to rule out hypopituitarism, as approximately 29% of patients with incidentally discovered partial empty sella have at least one hormone deficiency 1.
What the CT Shows
Your scan reveals:
- No acute problems: No bleeding, stroke, masses, or urgent abnormalities
- Age-related changes: Mild brain volume loss and compensatory ventricular enlargement (ex vacuo ventriculomegaly) - these are common with aging
- Atherosclerotic plaque: Indicates vascular disease in brain arteries - warrants cardiovascular risk factor management
- Partially empty sella: The key finding requiring follow-up
Understanding the Partially Empty Sella
The partially empty sella is a radiological finding where the pituitary gland appears flattened. While the radiologist mentions it "may be seen in the setting of idiopathic intracranial hypertension," this is only one possible association and does not mean you have this condition.
What You Need to Do Now
Get comprehensive pituitary hormone testing 1. According to the 2025 Pituitary Society guidelines, when empty sella is discovered incidentally, testing should assess:
- Thyroid function (TSH, free T4) - hypothyroidism occurs in 2.8% of incidental cases
- Adrenal function (morning cortisol, consider ACTH stimulation test) - hypocortisolism in 13.5%
- Gonadal function (testosterone in men, estradiol/LH/FSH in women) - hypogonadism in 8.5%
- Prolactin level - hyperprolactinemia in 2.9%
- Growth hormone axis (IGF-1) - deficiency in 12.5%
Risk Stratification
The evidence shows that partial empty sella carries lower risk than total empty sella 1. In your case:
- 29% of incidentally discovered partial empty sella patients have hormone deficiency - this is substantially lower than the 40.5% rate in all empty sella patients (which includes those with symptoms) 1
- Male sex, clinical symptoms, and traumatic brain injury increase risk 1
- Progression from partial to total empty sella can cause hormonal deterioration 1
Regarding Idiopathic Intracranial Hypertension (IIH)
The radiologist's mention of IIH is a differential consideration, not a diagnosis. You would need additional clinical features to suspect IIH 2, 3:
- Persistent headaches (present in 73% of IIH patients)
- Visual disturbances or vision loss
- Pulsatile tinnitus
- Papilledema on eye exam
- Being overweight/obese (particularly affects women of childbearing age)
If you have these symptoms, you need:
- Ophthalmology evaluation for papilledema
- Lumbar puncture to measure CSF opening pressure (elevated >25 cm H2O in IIH)
If you lack these symptoms, IIH is unlikely 2, 3.
Follow-Up Plan
Immediate Actions:
- Pituitary hormone panel - essential even without symptoms 1, 4, 5
- Clinical assessment - document any symptoms of hormone deficiency (fatigue, cold intolerance, sexual dysfunction, menstrual irregularities)
- Ophthalmology referral if you have headaches or visual symptoms 2
Long-Term Monitoring:
- If hormone testing is normal: MRI follow-up at 24-36 months to assess for progression 4
- If hormone deficiencies are found: targeted hormone replacement and closer monitoring 5
- Watch for new symptoms: fatigue, weight changes, sexual dysfunction, persistent headaches, vision changes
Common Pitfalls to Avoid
- Don't ignore this finding: While often benign, 29% of incidental cases have hormone problems 1
- Don't assume you have IIH: The radiologist noted an association, not a diagnosis - IIH requires specific clinical and CSF pressure criteria 2, 3
- Don't delay hormone testing: Hypocortisolism can be life-threatening if unrecognized during stress/illness 1
- Don't use CT for follow-up: MRI is the gold standard for evaluating pituitary and sellar abnormalities 4
Bottom Line
This is an incidental finding requiring endocrine evaluation but not an emergency. The absence of acute intracranial abnormalities is reassuring. Your main action item is pituitary hormone testing to identify any subclinical hormone deficiencies that could affect your quality of life and require treatment. The atherosclerotic changes warrant separate cardiovascular risk assessment and management.